Thousands of Xarelto users have brought federal lawsuits against the drug’s manufacturers alleging that the anticoagulant caused uncontrollable bleeding and severe injuries. Recent reports shed light on a how the drug made it to the market with FDA approval. The anticoagulant’s drug trial was based on what may have been a... Read more »

A January status conference has been scheduled to discuss the next steps in the talcum powder lawsuits currently pending in New Jersey state court. Judges Julio L. Mendez and Nelson C. Johnson of Atlantic County are expected to review the organizational structure of the multicounty litigation and provide status updates... Read more »

A plaintiff who recently filed a lawsuit against Invokana manufacturers Janssen Pharmaceuticals and Johnson & Johnson claims use of the drug to treat type 1 diabetes led to serious kidney damage. The lawsuit further accuses the companies of failing to warn consumers and the medical community about the risk associated with... Read more »

Anthony R. Allen has filed a lawsuit against Johnson & Johnson and Mitsubishi Tanabe Pharm Corp. He claims that the defendants’ prescription medication, Invokana, resulted in serious injuries that could have claimed his life. Allen is an Illinois resident who began using Invokana in December of 2014. The plaintiff’s Invokana... Read more »

A California woman has filed a product lability lawsuit against Janssen Pharmaceuticals and Johnson & Johnson, alleging that the defendants’ product, Invokana, caused serious complications. Jennifer Anzo filed the Invokana lawsuit late in October 2015 in the U.S. District Court for the Eastern District of California. She is demanding compensation... Read more »

A Philadelphia jury has ordered Janssen Pharmaceuticals — a Johnson & Johnson subsidiary — to pay $1.8 million to a man who developed breasts while taking the pharmaceutical giant’s antipsychotic drug Risperdal. Jurors determined that the company knew the prescription medication could trigger atypical breast growth, but failed to properly... Read more »

As concern over risks associated with the type 2 diabetes drug Invokana continues to rise, a new study has shown the same dangers seen with the drug in type 2 diabetes patients may also be present in those with type 1 diabetes. Researchers have found that off-label use of this... Read more »

A federal judge has issued an order to remand three talc-related cancer lawsuits back to Missouri state court. The lawsuits represent 237 plaintiffs who claim that their diagnoses of ovarian cancer were linked to their use of talcum powder products. In October 2015, U.S. District Judge Catherine Perry rejected the... Read more »

A 15-chapter expose on Johnson & Johnson by a Huffington Post reporter reveals how J&J’s drug Risperdal became a blockbuster product for the company. This drug was approved by the FDA in 1993 to treat severe mental disorders like bipolar disorder and schizophrenia. However, Risperdal has also been prescribed off-label to... Read more »

On August 7, 2015, five plaintiffs from as many states filed a joint complaint adding a Xarelto internal bleeding lawsuit to ongoing multi-district litigation (“MDL”). There are more than 500 Xarelto lawsuits already included in the MDL. The complex litigation is being overseen by U.S. District Judge Eldon Fallon in... Read more »